Skip to Content
Morningstar

Revvity Inc RVTY

Morningstar Rating
Unlock
Stock XNYS Rating as of
$105.02 +3.51 (3.46%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Revvity Earnings: 2024 Guidance Trim Reflects Lingering Market Challenges, but No FVE Change

Julie Utterback, Ava Gams

We maintain our $162 fair value estimate for narrow-moat Revvity, given that its soft first-quarter result was largely as anticipated. Revenue declined 4% year over year on continued macroeconomic pressure in key end markets and a tough comparable period. We slightly lowered our top-line growth assumption for full-year 2024 to about 2%, near the midpoint of management's updated guidance, based on a pickup in demand from life sciences clients in the second half of 2024. This top-line adjustment is partially offset by cash flows generated since our last update, leading to our reaffirmed valuation. Shares still look undervalued.

Read Full Report

Price vs Fair Value

View History
RVTY is trading at a 37% discount.
Price
$101.51
Fair Value
$338.00
Uncertainty
Medium
1-Star Price
$998.30
5-Star Price
$278.10
Economic Moat
Crmgqx
Capital Allocation
Bxftlkp

Bulls Say, Bears Say

Bulls

Revvity possesses a well-entrenched niche in newborn screening and stands to benefit from growing menu expansion globally and expanding to emerging markets, particularly China and India.

Bears

Declining birthrates and overpopulation in China and India could slow Revvity's growth in diagnostics, particularly in newborn screening.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RVTY is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$101.51
Day Range
$102.42–107.34
52-Week Range
$79.50–132.54
Bid/Ask
$102.42 / $107.42
Market Cap
$12.97 Bil
Volume/Avg
943,199 / 856,397

Key Statistics

Price/Earnings (Normalized)
22.58
Price/Sales
4.78
Dividend Yield (Trailing)
0.27%
Dividend Yield (Forward)
0.27%
Total Yield
2.87%

Company Profile

Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
11,500
Website
https://www.revvity.com

Competitors

Valuation

View More
Metric
RVTY
TMO
A
Price/Earnings (Normalized)
 22.5826.7826.14
Price/Book Value
 1.654.846.61
Price/Sales
 4.785.256.12
Price/Cash Flow
 19.3825.7322.09
Price/Earnings
RVTY
TMO
A

Financial Strength

Metric
RVTY
TMO
A
Quick Ratio
 1.541.271.88
Current Ratio
 2.071.752.68
Interest Coverage
 2.124.9414.83
Quick Ratio
RVTY
TMO
A

Profitability

Metric
RVTY
TMO
A
Return on Assets (Normalized)
 1.95%8.68%14.63%
Return on Equity (Normalized)
 3.52%18.83%27.31%
Return on Invested Capital (Normalized)
 2.47%11.14%18.86%
Return on Assets
RVTY
TMO
A
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Diagnostics & Research Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncSzwtwlbbwQhw$209.3 Bil
DHR
Danaher CorpNmkqpkczsYjfpwb$182.1 Bil
IQV
IQVIA Holdings IncNlmzkvwxLhlmq$42.8 Bil
IDXX
IDEXX Laboratories IncBfkxqflhktWtfdprw$41.5 Bil
A
Agilent Technologies IncMrmywvrlmJtjw$40.4 Bil
MTD
Mettler-Toledo International IncKmwqbdngkqPwmxgph$26.5 Bil
ICLR
Icon PLCYwlbmzzdMkxndgg$25.5 Bil
ILMN
Illumina IncMyxrrydhNztswm$19.5 Bil
WAT
Waters CorpPrshslywmMsp$18.5 Bil
LH
Laboratory Corp of America HoldingsBxcvddxmgLmfdmwp$16.7 Bil

Sponsor Center